Kobe, Japan

Koji Kondo


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 102(Granted Patents)


Company Filing History:


Years Active: 1998-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Koji Kondo: Innovator in Pharmaceutical Dosage Forms

Introduction

Koji Kondo is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of 2 patents, Kondo's work focuses on enhancing the effectiveness of pharmaceutical compositions.

Latest Patents

Kondo's latest patents include a pharmaceutical dosage form with multiple enteric polymer coatings. This invention relates to a pharmaceutical composition designed for peroral administration in humans or lower animals. It specifically addresses the gastrointestinal tract, which comprises a small intestine and a colon, ensuring effective delivery of medication. Another notable patent is the Bisacodyl dosage form with multiple enteric polymer coatings for colonic administration, further showcasing his expertise in creating advanced pharmaceutical solutions.

Career Highlights

Throughout his career, Kondo has been associated with The Procter & Gamble Company, where he has applied his innovative ideas to develop new products. His work has contributed to the advancement of pharmaceutical technologies, making medications more effective and patient-friendly.

Collaborations

Kondo has collaborated with several professionals in his field, including Gary Robert Kelm and Akio Nakajima. These partnerships have allowed him to enhance his research and development efforts, leading to successful innovations in pharmaceutical formulations.

Conclusion

Koji Kondo's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the way medications are formulated and administered, improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…